Company Presentation • 26 Aug 2026 17:00
Q2 2026
Company Presentation • 29 Mar 2026 15:30
Q4 2025
Company Presentation • 01 May 2026 16:00
Corporate presentation
No more presentations
𝛼SK or SearchENTITY
Insilico Medicine (3696 HK)
Insilico Medicine (3696 HK)
69
Analysis
Health Care • Hong Kong
Insilico Medicine is an artificial intelligence (AI)-based biotechnology company that applies AI solutions to drug discovery and development, leveraging its proprietary Pharma.AI platform to identify and design early-stage drug candidates. The company develops novel drugs for various diseases, including cancer, fibrosis, immunity, and central nervous system disorders, and predicts clinical trial outcomes. Insilico Medicine was founded in 2014 and is headquartered in New Territories, Hong Kong.
morex